Directory
>
Mitchell Ho
Mitchell Ho
Editor In Chief, Antibody Therapeutics | National Cancer Institute (NCI)
Washington, District of Columbia, United States
Mitchell Ho
Summary
Mitchell Ho is a distinguished Senior Investigator and Deputy Chief at the Laboratory of Molecular Biology, National Cancer Institute, NIH, with a profound expertise in cancer research and antibody engineering. He has a rich background in biochemistry, drug development, and molecular biology, making significant contributions to the field through his role as Editor In Chief for Antibody Therapeutics. His work focuses on innovative therapeutic approaches, including CAR-T cell treatments for liver cancer. With over a decade of experience at the National Cancer Institute, Mitchell has been pivotal in advancing antibody engineering and developing cancer-targeting strategies. He also has a strong academic foundation, holding a Ph.D. from the University of Illinois at Urbana-Champaign. His leadership experience is complemented by his role in teaching biochemistry at the FAES Graduate School. Mitchell's passion for research and education drives his commitment to improving cancer therapies and mentoring the next generation of scientists.
Mitchell Ho
Work Experience
Editor In Chief, Antibody Therapeutics at
Oxford University Press India
June 2018 - Present
Director, NCI Antibody Engineering Program at
National Cancer Institute (NCI)
March 2018 - Present
Deputy Chief, Laboratory of Molecular Biology at
National Cancer Institute (NCI)
July 2008 - Present
Chair, Department of Biochemistry, FAES Graduate School at the NIH at
Foundation for Advanced Education in the Sciences (FAES)
September 2006 - December 2022
Mitchell Ho
Education
University of Illinois Urbana-Champaign, Doctor Of Philosophy (Ph.D.)
Frequently Asked Questions about Mitchell Ho
What is Mitchell Ho email address?
Mitchell Ho's primary email address is ***********@oup.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mitchell Ho work for?
Mitchell Ho is a Editor In Chief, Antibody Therapeutics at National Cancer Institute (NCI), a company specializing in Scientific Research & Development Services.
Where Mitchell Ho graduated from?
Mitchell Ho holds a degree in from University of Illinois Urbana-Champaign.
How can I directly contact Mitchell Ho?
To contact Mitchell Ho directly, you can use the email address ***********@oup.com. Complete contact information is available upon registration with Muraena.
Who is Mitchell Ho?
Mitchell Ho is a distinguished Senior Investigator and Deputy Chief at the Laboratory of Molecular Biology, National Cancer Institute, NIH, with a profound expertise in cancer research and antibody engineering. He has a rich background in biochemistry, drug development, and molecular biology, making significant contributions to the field through his role as Editor In Chief for Antibody Therapeutics. His work focuses on innovative therapeutic approaches, including CAR-T cell treatments for liver cancer. With over a decade of experience at the National Cancer Institute, Mitchell has been pivotal in advancing antibody engineering and developing cancer-targeting strategies. He also has a strong academic foundation, holding a Ph.D. from the University of Illinois at Urbana-Champaign. His leadership experience is complemented by his role in teaching biochemistry at the FAES Graduate School. Mitchell's passion for research and education drives his commitment to improving cancer therapies and mentoring the next generation of scientists.
Mitchell`s contact details
***********@oup.com
Colleagues
Branch Chief, Office of Workforce Planning and Development
Section Chief
Branch Chief, Management Support Branch, Office of Management Policy & Compliance
Chief, Data Ecosystems Branch at NCI CBIIT
Associate Branch Chief
Chief, Structural Glycobiology Section, CCR, NCI
Founder And Co-Chair Cancer And Aging Interest Group
Chief, Outcomes Research Branch
Branch Chief
Chief, Cancer Publications Branch